AGT and colorectal cancer: Our findings on the contrasting risk of AD and ADRD between angiotensin-II stimulating vs. inhibiting antihypertensive drugs in a large cohort of men and women with colorectal cancer support the results and conclusions of previous studies by van Dalen et al. (10), Marcum et al. (11), and other researchers (12–22).